A citation-based method for searching scientific literature

Flavia S Donaires, Raquel M Alves-Paiva, Fernanda Gutierrez-Rodrigues, Fernanda Borges da Silva, Maria Florencia Tellechea, Lilian Figueiredo Moreira, Barbara A Santana, Fabiola Traina, Cynthia E Dunbar, Thomas Winkler, Rodrigo T Calado. Stem Cell Res 2019
Times Cited: 4







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Posttranscriptional modulation of TERC by PAPD5 inhibition rescues hematopoietic development in dyskeratosis congenita.
Wilson Chun Fok, Siddharth Shukla, Alexandre Teixeira Vessoni, Kirsten Ann Brenner, Roy Parker, Christopher M Sturgeon, Luis Francisco Zirnberger Batista. Blood 2019
17
50


Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs.
Thomas Winkler, So Gun Hong, Jake E Decker, Mary J Morgan, Chuanfeng Wu, William M Hughes, Yanqin Yang, Danny Wangsa, Hesed M Padilla-Nash, Thomas Ried,[...]. J Clin Invest 2013
48
50

Advances in the understanding of dyskeratosis congenita.
Amanda J Walne, Inderjeet Dokal. Br J Haematol 2009
111
50

The telomere syndromes.
Mary Armanios, Elizabeth H Blackburn. Nat Rev Genet 2012
547
50


p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
Wilson Chun Fok, Evandro Luis de Oliveira Niero, Carissa Dege, Kirsten Ann Brenner, Christopher Michael Sturgeon, Luis Francisco Zirnberger Batista. Stem Cell Reports 2017
15
50

DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
Meng Zhang, Yu Pan, Ranran Jiang, Pingfu Hou, Haixia Shan, Fang Chen, Tao Jiang, Jin Bai, Junnian Zheng. Oncol Rep 2018
5
50

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50

Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasion.
Fa-An Miao, Kun Chu, Hai-Rong Chen, Meng Zhang, Pei-Cong Shi, Jin Bai, Yong-Ping You. Invest New Drugs 2019
11
50

Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
171
25

Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.
Yutaka Maeda, Wendy W Hwang-Verslues, Gang Wei, Takuya Fukazawa, Mary L Durbin, Laurie B Owen, Xuan Liu, Frances M Sladek. Biochem J 2006
31
25


The role of telomeres and telomerase in cirrhosis and liver cancer.
Jean-Charles Nault, Massih Ningarhari, Sandra Rebouissou, Jessica Zucman-Rossi. Nat Rev Gastroenterol Hepatol 2019
53
25

Deregulation of hepatocyte nuclear factor 4 (HNF4)as a marker of epithelial tumors progression.
N L Lazarevich, D A Shavochkina, D I Fleishman, I F Kustova, O V Morozova, E S Chuchuev, Y I Patyutko. Exp Oncol 2010
43
25

Constitutional telomerase mutations are genetic risk factors for cirrhosis.
Rodrigo T Calado, Jennifer Brudno, Paulomi Mehta, Joseph J Kovacs, Colin Wu, Marco A Zago, Stephen J Chanock, Thomas D Boyer, Neal S Young. Hepatology 2011
102
25

The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4α.
Laura Santangelo, Alessandra Marchetti, Carla Cicchini, Alice Conigliaro, Beatrice Conti, Carmine Mancone, Jessica A Bonzo, Frank J Gonzalez, Tonino Alonzi, Laura Amicone,[...]. Hepatology 2011
79
25

Differentiation of hepatocytes from pluripotent stem cells.
Sunil K Mallanna, Stephen A Duncan. Curr Protoc Stem Cell Biol 2013
67
25

Generation of safe and therapeutically effective human induced pluripotent stem cell-derived hepatocyte-like cells for regenerative medicine.
Kazuo Takayama, Naoki Akita, Natsumi Mimura, Rina Akahira, Yukimasa Taniguchi, Makoto Ikeda, Fuminori Sakurai, Osamu Ohara, Tomohiro Morio, Kiyotoshi Sekiguchi,[...]. Hepatol Commun 2017
33
25


Diagnostic utility of telomere length testing in a hospital-based setting.
Jonathan K Alder, Vidya Sagar Hanumanthu, Margaret A Strong, Amy E DeZern, Susan E Stanley, Clifford M Takemoto, Ludmila Danilova, Carolyn D Applegate, Stephen G Bolton, David W Mohr,[...]. Proc Natl Acad Sci U S A 2018
71
25

p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.
Jelena Krstic, Markus Galhuber, Tim J Schulz, Michael Schupp, Andreas Prokesch. Int J Mol Sci 2018
19
25

Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.
Stefanie U Wiemann, Ande Satyanarayana, Martina Tsahuridu, Hans L Tillmann, Lars Zender, Juergen Klempnauer, Peer Flemming, Sonia Franco, Maria A Blasco, Michael P Manns,[...]. FASEB J 2002
327
25

Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients.
Suneet Agarwal, Yuin-Han Loh, Erin M McLoughlin, Junjiu Huang, In-Hyun Park, Justine D Miller, Hongguang Huo, Maja Okuka, Rosana Maria Dos Reis, Sabine Loewer,[...]. Nature 2010
223
25

A Screen Using iPSC-Derived Hepatocytes Reveals NAD+ as a Potential Treatment for mtDNA Depletion Syndrome.
Ran Jing, James L Corbett, Jun Cai, Gyda C Beeson, Craig C Beeson, Sherine S Chan, David P Dimmock, Lynn Lazcares, Aron M Geurts, John J Lemasters,[...]. Cell Rep 2018
20
25

Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks.
Jean-Philippe Babeu, François Boudreau. World J Gastroenterol 2014
92
25


HNF4: a central regulator of hepatocyte differentiation and function.
Alistair J Watt, Wendy D Garrison, Stephen A Duncan. Hepatology 2003
199
25

The molecular functions of hepatocyte nuclear factors - In and beyond the liver.
Hwee Hui Lau, Natasha Hui Jin Ng, Larry Sai Weng Loo, Joanita Binte Jasmen, Adrian Kee Keong Teo. J Hepatol 2018
72
25

Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
Luis F Z Batista, Matthew F Pech, Franklin L Zhong, Ha Nam Nguyen, Kathleen T Xie, Arthur J Zaug, Sharon M Crary, Jinkuk Choi, Vittorio Sebastiano, Athena Cherry,[...]. Nature 2011
176
25

p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease.
Zhibin Yan, Xiaokang Miao, Bangzhi Zhang, Junqiu Xie. Life Sci 2018
8
25

Distributed hepatocytes expressing telomerase repopulate the liver in homeostasis and injury.
Shengda Lin, Elisabete M Nascimento, Chandresh R Gajera, Lu Chen, Patrick Neuhöfer, Alina Garbuzov, Sui Wang, Steven E Artandi. Nature 2018
87
25

Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
Bei-Fang Ning, Jin Ding, Chuan Yin, Wei Zhong, Kun Wu, Xin Zeng, Wen Yang, Yue-Xiang Chen, Jun-Ping Zhang, Xin Zhang,[...]. Cancer Res 2010
152
25

A Doxycycline-Inducible System for Genetic Correction of iPSC Disease Models.
Xiuli Sim, Fabian L Cardenas-Diaz, Deborah L French, Paul Gadue. Methods Mol Biol 2016
15
25

Structural biology of telomeres and telomerase.
Eric M Smith, Devon F Pendlebury, Jayakrishnan Nandakumar. Cell Mol Life Sci 2020
24
25

Stop pulling my strings - what telomeres taught us about the DNA damage response.
Eros Lazzerini-Denchi, Agnel Sfeir. Nat Rev Mol Cell Biol 2016
86
25

The promoter of human telomerase reverse transcriptase is activated during liver regeneration and hepatocyte proliferation.
Hüseyin Sirma, Mukesh Kumar, Jitendra K Meena, Britta Witt, Julia M Weise, Andre Lechel, Satyanarayana Ande, Vadim Sakk, Christiane Guguen-Guillouzo, Lars Zender,[...]. Gastroenterology 2011
24
25

Telomerase Mechanism of Telomere Synthesis.
R Alex Wu, Heather E Upton, Jacob M Vogan, Kathleen Collins. Annu Rev Biochem 2017
91
25

Syndromes of telomere shortening.
Mary Armanios. Annu Rev Genomics Hum Genet 2009
228
25

Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.
H-Y Yue, C Yin, J-L Hou, X Zeng, Y-X Chen, W Zhong, P-F Hu, X Deng, Y-X Tan, J-P Zhang,[...]. Gut 2010
92
25

iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery.
James L Corbett, Stephen A Duncan. Front Med (Lausanne) 2019
29
25

Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.
Kunitoshi Chiba, Franziska K Lorbeer, A Hunter Shain, David T McSwiggen, Eva Schruf, Areum Oh, Jekwan Ryu, Xavier Darzacq, Boris C Bastian, Dirk Hockemeyer. Science 2017
121
25

Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
Ling-Yang Hao, Mary Armanios, Margaret A Strong, Baktiar Karim, David M Feldser, David Huso, Carol W Greider. Cell 2005
200
25

Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery.
K L Rudolph, S Chang, M Millard, N Schreiber-Agus, R A DePinho. Science 2000
283
25

The Spectrum of Hepatic Involvement in Patients With Telomere Disease.
Devika Kapuria, Gil Ben-Yakov, Rebecca Ortolano, Min Ho Cho, Or Kalchiem-Dekel, Varun Takyar, Shilpa Lingala, Naveen Gara, Michele Tana, Yun Ju Kim,[...]. Hepatology 2019
13
25

Hepatocyte Nuclear Factor 4 Alpha Promotes Definitive Endoderm Differentiation from Human Induced Pluripotent Stem Cells.
Morifumi Hanawa, Kazuo Takayama, Fuminori Sakurai, Masashi Tachibana, Hiroyuki Mizuguchi. Stem Cell Rev Rep 2017
7
25

Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.
M A Blasco, H W Lee, M P Hande, E Samper, P M Lansdorp, R A DePinho, C W Greider. Cell 1997
25



Telomerase gene mutations are associated with cirrhosis formation.
Daniel Hartmann, Ujala Srivastava, Michaela Thaler, Karin N Kleinhans, Gisèle N'kontchou, Annika Scheffold, Kerstin Bauer, Ramona F Kratzer, Natalia Kloos, Sarah-Fee Katz,[...]. Hepatology 2011
94
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.